Fed. Circ. Upholds Generics' Win In Abilify Patent Suit
A Federal Circuit panel on Thursday rejected Otsuka Pharmaceutical Co. Ltd.'s suit against pharmaceutical companies seeking to market generic versions of the antipsychotic drug Abilify, upholding a New Jersey federal judge's...To view the full article, register now.
Already a subscriber? Click here to view full article